Concord Drugs Ltd share price logo

Concord Drugs Ltd Share Price

(538965)

₹33.92.36%

as on 11:39AM, 21 Feb 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Concord Drugs Ltd Performance

  • Day's Low

    ₹33.12
    Day's Price Range
    ₹33.9
  • 52 Week's Low

    52 Week's High

    ₹28.5
    52-Week Price Range
    ₹44.96
1 Month Return-13.46 %
3 Month Return-7.33 %
1 Year Return-17.59 %
Previous Close₹33.12
Open₹33.90
Volume870.00
Upper Circuit-
Lower Circuit-
Market Cap₹33.12Cr

Concord Drugs Ltd Key Statistics

P/E Ratio

-828

PEG Ratio

752.73

Market Cap

₹33.12 Cr

P/B Ratio

1.04

EPS

0.47

Dividend Yield

0

Sector

Pharmaceuticals

ROE

1.28

Key events for Concord Drugs Ltd

  • Concord Drugs Reports Mixed Financial Performance - 15 Jan, 2025

    Concord Drugs reported a 14.66% decline in net sales to Rs 10.77 crore for December 2024, while net profit rose 192.68% to Rs 0.22 crore. EBITDA increased by 135.71%. The stock has seen a -3.28% return over the last 6 months and -14.53% over the last year.

Insights on Concord Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -0.34 Cr → 0.23 Cr (in ₹), with an average increase of 447.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, Concord Drugs stock has moved up by 2.6%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 45.61% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 54.39% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 63.8% return, outperforming this stock by 81.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 133.2% return, outperforming this stock by 122.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 12.37 Cr → 10.8 Cr (in ₹), with an average decrease of 12.7% per quarter

Concord Drugs Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹12.78Cr (-)₹15.64Cr (↑22.38%)₹11.69Cr (↓25.26%)₹12.36Cr (↑5.73%)₹10.80Cr (↓12.62%)
Net Income-₹0.24Cr (-)-₹0.34Cr (↑41.67%)₹0.03Cr (↓108.82%)₹0.04Cr (↑33.33%)₹0.23Cr (↑475.00%)
Net Profit Margin-1.88% (-)-2.17% (↑15.43%)0.26% (↓111.98%)0.32% (↑23.08%)2.13% (↑565.62%)

Concord Drugs Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
54.39%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
45.61%
0.00
Others
0%
0.00

Concord Drugs Ltd Key Indicators

Details20202021202220232024
Return On Equity %1.421.595.772.961.28

Concord Drugs Ltd Valuation

Concord Drugs Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-961.50x)

January 3, 2025

Today (-828.00x)

February 20, 2025

Industry (51.76x)

February 20, 2025

Highest (791.40x)

July 3, 2024

LowHigh

Concord Drugs Ltd Earnings and Dividends

  • Concord Drugs Ltd Earnings Results

    Concord Drugs Ltd’s net profit jumped 195.83% since last year same period to ₹0.23Cr in the Q3 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated 475% jump in its net profits since last 3-months.

    Read More about Earnings Results

Concord Drugs Ltd Technicals Summary

Bearish

Neutral

Bullish

Neutral

Concord Drugs Ltd is currently in a Neutral trading position according to technical analysis indicators.

Concord Drugs Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹33.12 Cr23.58%0.67₹1 Cr₹44 Cr
NA₹686.80 Cr124.79%0.91₹55 Cr₹575 Cr
NA₹103.20 Cr31.27%0.55NANA
NA₹671.21 Cr28.67%0.69₹5 Cr₹1,684 Cr
NA₹98.19 Cr37.72%0.73NANA

About Concord Drugs Ltd

Concord Drugs Limited, established in 1995, is one of the most reputable pharmaceutical companies in India that manufactures Finished Pharmaceutical Formulations such as Injectables, Small Volume Parenterals, Dry Powder, Tissue BioAdhesive Tablets, Capsules and Ophthalmic Preparations, and Readytofill Pellets. They specialize in cGMP contract manufacturing and FormulationFillFinish facility providing comprehensive pharmaceutical development and manufacturing services for drug products. Through the use of state-of-the-art technology that ensures the highest level of process integrity and product quality, they strive to provide their customers with an end-to-end solution to their various pharmaceutical product needs. In order to meet the standards set by regulatory bodies, their two manufacturing facilities are designed to comply with the prerequisites of these governing bodies.

Share Price: ₹33.90 per share as on 21 Feb, 2025 11:39 AM
Market Capitalisation: ₹33.12Cr as of today
Revenue: ₹10.80Cr as on December 2024 (Q4 24)
Net Profit: ₹0.23Cr as on December 2024 (Q4 24)
Chairperson Name: S Nagi Reddy
OrganisationConcord Drugs Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Concord Drugs Ltd

What is Concord Drugs Ltd price today?

Concord Drugs Ltd share price today stands at ₹33.9, Open: ₹33.9, Previous Close: ₹33.12, High: ₹33.9, Low: ₹33.12, 52 Week High: ₹44.96, 52 Week Low: ₹28.5.

How to Buy Concord Drugs Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Concord Drugs Ltd shares

Is Concord Drugs Ltd listed on NSE?

Concord Drugs Ltd is not listed on NSE

Is Concord Drugs Ltd listed on BSE?

Concord Drugs Ltd is listed on BSE

What are today's High and Low prices of Concord Drugs Ltd?

  • Today's highest price of Concord Drugs Ltd is ₹33.9.
  • Today's lowest price of Concord Drugs Ltd is ₹33.12.

What are today's traded volumes of Concord Drugs Ltd?

Today's traded volume of Concord Drugs Ltd(538965) is 870.00.

What is today's market capitalisation of Concord Drugs Ltd?

Today's market capitalisation of Concord Drugs Ltd(538965) is ₹33.12Cr.

What is the 52 Week High and Low Range of Concord Drugs Ltd?

Concord Drugs Ltd (538965)
Price
52 Week High
₹44.96
52 Week Low
₹28.5

How much percentage Concord Drugs Ltd is down from its 52 Week High?

Concord Drugs Ltd (538965) share price is ₹33.9. It is down -24.60% from its 52 Week High price of ₹44.96

How much percentage Concord Drugs Ltd is up from its 52 Week low?

Concord Drugs Ltd (538965) share price is ₹33.9. It is up 18.95% from its 52 Week Low price of ₹28.5

What are the historical returns of Concord Drugs Ltd?

Concord Drugs Ltd (538965)
Returns
1 Day Returns
0.78%
1 Month Returns
-13.46%
3 Month Returns
-7.33%
1 Year Returns
-17.59%

What is the PE ratio of Concord Drugs Ltd today?

PE Ratio of Concord Drugs Ltd is -828

PE ratio = Concord Drugs Ltd Market price per share / Concord Drugs Ltd Earnings per share